This new equipment of excellence will allow the continuous updating of specialists and will encourage the spirit of research, innovation and continuous training of healthcare professionals. Companies, organisations, local councils and other health and hospital centres will be able to use the SimHUB for staff requiring basic healthcare training
In view of the current epidemiological situation, from Tuesday 12 April, the Bellvitge University Hospital allows a visitor for COVID-19 patients.
The manager of the ICS’s Southern Metropolitan Area, Dr Montserrat Figuerola, has introduced this Thursday 7 April the mayoress of L'Hospitalet, Núria Marín, as the main speaker of a new session of this informative breakfast cycle. Dr Figuerola presented the shared project of the Bellvitge Biosanitary Cluster (Bellvitge University Hospital, Faculty of Medicine and Health Sciences from UB’s Bellvitge Campus, Catalan Institute of Oncology, IDIBELL Research Foundation and Sant Joan de Déu Hospital)
The Talents programme grants, promoted by the Catalunya La Pedrera Foundation, have materialised the translational research projects by 10 health professionals from Bellvitge University Hospital (HUB), Viladecans Hospital and ICS South Metropolitan Primary Care during 2020 and 2021. This Monday, 4 April, the Talents Day was held at La Pedrera-Casa Milà. At the ceremony, diplomas were awarded in recognition of their research work
The Catalan Institute of Health (ICS) has organised a conference to present the ERAS programme, which prepares patients for better functional recovery after surgery. Regarding the Bellvitge University Hospital (HUB), the programme’s results and implementation model were presented. In this model, the coordinating role of the nurse stands out
The new Transversal Unit for the Study of the Human Microbiome (UTMAH) will promote microbiota transplantation and research to be used in different pathologies. The Unit is involved in the development of a pioneering microbiota transplantation system that replaces colonoscopy transfer with capsules that can be ingested by the patient